{"id":126665,"date":"2025-04-30T19:48:46","date_gmt":"2025-04-30T19:48:46","guid":{"rendered":"https:\/\/teknomers.com\/en\/sanofi-finalizes-the-sale-of-opella-for-10-billion-euros\/"},"modified":"2025-04-30T19:48:48","modified_gmt":"2025-04-30T19:48:48","slug":"sanofi-finalizes-the-sale-of-opella-for-10-billion-euros","status":"publish","type":"post","link":"https:\/\/teknomers.com\/en\/sanofi-finalizes-the-sale-of-opella-for-10-billion-euros\/","title":{"rendered":"Sanofi finalizes the sale of Opella for 10 billion euros"},"content":{"rendered":"<p><\/p>\n<div id=\"\">\n<figure class=\"article__media\"> <picture class=\"article__media\"><source srcset=\" https:\/\/img.lemde.fr\/2025\/04\/30\/0\/0\/5452\/3641\/556\/0\/75\/0\/49e3750_sirius-fs-upload-1-gunmryxhy702-1746033670341-681052.jpg 556w, https:\/\/img.lemde.fr\/2025\/04\/30\/0\/0\/5452\/3641\/600\/0\/75\/0\/49e3750_sirius-fs-upload-1-gunmryxhy702-1746033670341-681052.jpg 600w, https:\/\/img.lemde.fr\/2025\/04\/30\/0\/0\/5452\/3641\/664\/0\/75\/0\/49e3750_sirius-fs-upload-1-gunmryxhy702-1746033670341-681052.jpg 664w, https:\/\/img.lemde.fr\/2025\/04\/30\/0\/0\/5452\/3641\/700\/0\/75\/0\/49e3750_sirius-fs-upload-1-gunmryxhy702-1746033670341-681052.jpg 700w, https:\/\/img.lemde.fr\/2025\/04\/30\/0\/0\/5452\/3641\/800\/0\/75\/0\/49e3750_sirius-fs-upload-1-gunmryxhy702-1746033670341-681052.jpg 800w\" sizes=\"(min-width: 1024px) 556px, 100vw\" alt=\"Usine Sanofi \u00e0 Lyon, le 30\u00a0septembre 2023.\" width=\"664\" height=\"443\"><\/source><\/picture> <noscript> <img decoding=\"async\" src=\"https:\/\/img.lemde.fr\/2025\/04\/30\/0\/0\/5452\/3641\/664\/0\/75\/0\/49e3750_sirius-fs-upload-1-gunmryxhy702-1746033670341-681052.jpg\" alt=\"Sanofi factory in Lyon, September 30, 2023.\"\/> <\/noscript><figcaption class=\"article__legend\" aria-hidden=\"true\">Sanofi factory in Lyon, September 30, 2023.  <span class=\"article__credit\" aria-hidden=\"true\">Gonzalo Fuentes \/ Reuters<\/span>  <\/figcaption><\/figure>\n<p class=\"article__paragraph  \">It is the epilogue of a soap opera that agitated the political class in the fall of 2024. Sanofi announced, Wednesday, April 30, the finalization of the sale of 50 % of Opella&#8217;s shares, parent company in Doliprane, the best -selling drug in France. It is now the American investment fund CD &#038; R, which will preside the destinies of the ex-Filiale of Sanofi.<\/p>\n<section class=\"catcher catcher--favoris\">\n<div class=\"catcher__content\"><span class=\"catcher__title catcher__title--hide\">Read also |<\/span><span class=\"catcher__desc\">  <span class=\"icon__premium\"><span class=\"sr-only\">Article reserved for our subscribers<\/span><\/span>    Doliprane: The State gives the green light to a redemption by the American CD&#038;R and is invited to the capital <\/span> <\/div>\n<p> <button class=\"lmd-btn-icon lmd-btn-icon--primary lmd-btn-icon--m js-lmd-dropdown-favorite-toggler\" aria-expanded=\"false\" aria-haspopup=\"true\" aria-controls=\"lmd-dropdown-favorite\" aria-label=\"Lire plus tard\" data-article-id=\"3394482\" data-position=\"lire aussi\" data-url=\"https:\/\/www.lemonde.fr\/economie\/article\/2024\/10\/21\/doliprane-l-etat-donne-son-feu-vert-a-un-rachat-par-l-americain-cd-r-et-s-invite-au-capital_6357451_3234.html\" data-status=\"\"> <span class=\"icon__favorites\"\/> <span class=\"js-btn-icon-tooltip\" aria-hidden=\"true\">Read later<\/span> <\/button> <\/p>\n<\/section>\n<p class=\"article__paragraph  \">Eager to concentrate his efforts on his portfolio of innovative treatments and vaccines, Sanofi had expressed his intention, in September 2023, to separate from his subsidiary of prescription drugs and food supplements.<\/p>\n<p class=\"article__paragraph  \">A year later, on October 21, 2024, the Tricolore group announced that it had initiated exclusive negotiations with the American CD&#038;R, in order to give it half of the capital of its consumer health division. The completed transaction, Sanofi, which specifies having <em>&#8220;Received a total net amount in cash in the order of 10 billion euros&#8221;<\/em>therefore retains 48.2 % of Opella&#8217;s shares.<\/p>\n<h2 class=\"article__sub-title\">Health sovereignty<\/h2>\n<p class=\"article__paragraph  \">The Bpifrance public bank will hold the remaining 1.8 % of the capital of the company and obtains a headquarters on the board of directors. The government had negotiated this acquisition after the bronca aroused in the fall by the announcement of the transfer. Elected officials of all stripes were then brought up against sale, worried about possible consequences on employment and health sovereignty of this passage under foreign pavilion.<\/p>\n<p class=\"reading-mode-only \"><strong>You have 34.12% of this article to read. The rest is reserved for subscribers.<\/strong><\/p>\n<\/p><\/div>\n<p><a href=\"https:\/\/teknomers.com\/en\">Tm-En-1<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sanofi factory in Lyon, September 30, 2023. Gonzalo Fuentes \/ Reuters It is the epilogue of a soap opera that agitated the political class in the fall of 2024. Sanofi announced, Wednesday, April 30, the finalization of the sale of 50 % of Opella&#8217;s shares, parent company in Doliprane, the best -selling drug in France. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":126666,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[377,4849,27497,32562,1801,23324],"class_list":["post-126665","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-billion","tag-euros","tag-finalizes","tag-opella","tag-sale","tag-sanofi"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/posts\/126665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/comments?post=126665"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/posts\/126665\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/media\/126666"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/media?parent=126665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/categories?post=126665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/tags?post=126665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}